CELL BIOTECHNOLOGY GROUP INC.
Home
About Us
Corporate Introduction
Cooperation & Communication
Social Mission
Company Events
Research Project
Cell Treatment Research
Service Support
Technical Expert
Management Team
Trade News
Updated Information
Industry Trends
Testimonials
Market
Research
Testimonials
Contact Us
Cell Treatment Research
Cell Treatment Research
Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors
2019-11-14
TCF7L2 Variation and Proliferative Diabetic Retinopathy
2019-11-14
CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabete
2019-11-12
All about hematopoietic stem cell transplantation
2019-11-01
Stem cell therapy for rheumatoid arthritis
2019-11-01
What is a cell?
2019-10-25
A cure for Parkinson's? Replacing damaged brain cells shows promise
2019-10-25
Type 1 diabetes: Reprogramming liver cells may lead to new treatments
2019-10-25
How immune cells can be controlled to kill cancer
2019-10-25
Stem cell therapy: is the US missing a trick?
2019-10-25
上一页
1
2
3
4
下一页
©2022 CELL BIOTECHNOLOGY GROUP INC. All Rights Reserved Tel:+1-647-4090807